Juan Bergua

5.7k total citations
59 papers, 2.3k citations indexed

About

Juan Bergua is a scholar working on Hematology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Juan Bergua has authored 59 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 20 papers in Pathology and Forensic Medicine and 19 papers in Molecular Biology. Recurrent topics in Juan Bergua's work include Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (20 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Juan Bergua is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Lymphoma Diagnosis and Treatment (20 papers) and Chronic Lymphocytic Leukemia Research (13 papers). Juan Bergua collaborates with scholars based in Spain, United States and Argentina. Juan Bergua's co-authors include Rafael Solana, Raquel Tarazona, Beatriz Sánchez-Correa, Javier G. Casado, Sara Morgado, Salut Brunet, Inmaculada Gayoso, María José Arcos, José D. González and Pau Montesinos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Juan Bergua

53 papers receiving 2.3k citations

Peers

Juan Bergua
Guillermo Martı́n Spain
Guillermo Debén Spain
Shuichi Miyawaki Japan
Joan Bargay Spain
Shin Fujisawa Japan
FR Appelbaum United States
Enrico Gottardi Italy
Gandhi Damaj France
Akihiko Yokohama Japan
W. Lange Germany
Guillermo Martı́n Spain
Juan Bergua
Citations per year, relative to Juan Bergua Juan Bergua (= 1×) peers Guillermo Martı́n

Countries citing papers authored by Juan Bergua

Since Specialization
Citations

This map shows the geographic impact of Juan Bergua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Bergua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Bergua more than expected).

Fields of papers citing papers by Juan Bergua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Bergua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Bergua. The network helps show where Juan Bergua may publish in the future.

Co-authorship network of co-authors of Juan Bergua

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Bergua. A scholar is included among the top collaborators of Juan Bergua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Bergua. Juan Bergua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartlett, Nancy L., Uwe Hahn, Won Seog Kim, et al.. (2025). Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 43(9). 1061–1072. 7 indexed citations
2.
Belada, David, Kateřina Kopečková, Juan Bergua, et al.. (2023). Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study. Blood. 142(16). 1348–1358. 12 indexed citations
3.
Martı́n, Alejandro, Mónica Baile, Guillermo Rodríguez‐Domínguez, et al.. (2023). Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO. British Journal of Haematology. 203(2). 202–211.
4.
Vázquez, Lourdes, et al.. (2020). Micafungin as antifungal prophylaxis in non-transplanted haemotological patients. Revista Española de Quimioterapia. 33(1). 44–48. 3 indexed citations
5.
Hassouneh, Fakhri, Nelson López-Sejas, Alejandra Pera, et al.. (2020). Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia. Cancers. 12(8). 2171–2171. 28 indexed citations
6.
Sánchez-Correa, Beatriz, Fakhri Hassouneh, Nelson López-Sejas, et al.. (2019). DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy. Cancers. 11(6). 877–877. 168 indexed citations
7.
Montesinos, Pau, Juan Bergua, Jordi Esteve, et al.. (2019). Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus. Annals of Hematology. 98(11). 2467–2483. 8 indexed citations
8.
Sánchez-Correa, Beatriz, Juan Bergua, Alejandra Pera, et al.. (2017). In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients. Frontiers in Immunology. 8. 931–931. 29 indexed citations
9.
Tarazona, Raquel, Beatriz Sánchez-Correa, Ignacio Casas-Avilés, et al.. (2016). Immunosenescence: limitations of natural killer cell-based cancer immunotherapy. Cancer Immunology Immunotherapy. 66(2). 233–245. 36 indexed citations
10.
Ribera, Josep‐María, Mireia Morgades, Isabel Granada, et al.. (2016). Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Leukemia & lymphoma. 58(1). 145–152. 6 indexed citations
11.
Sánchez-Correa, Beatriz, Carmen Campos, Alejandra Pera, et al.. (2015). Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?. Cancer Immunology Immunotherapy. 65(4). 453–463. 40 indexed citations
12.
13.
Sánchez-Correa, Beatriz, Juan Bergua, Carmen Campos, et al.. (2013). Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine. 61(3). 885–891. 155 indexed citations
14.
Knapper, Steven, Timothy Chevassut, Rafael F. Duarte, et al.. (2013). Elacytarabine in relapsed/refractory acute myeloid leukaemia: An evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile. Leukemia Research. 38(3). 346–351. 2 indexed citations
15.
Bergua, Juan, et al.. (2009). Diarrhoea caused by colonic relapse of follicular lymphoma. British Journal of Haematology. 146(5). 466–466. 1 indexed citations
16.
17.
Gelbart, Terri, Ellinor Ristoff, Juan Bergua, et al.. (2007). Chronic non-spherocytic hemolytic anemia associated with severe neurological disease due to  -glutamylcysteine synthetase deficiency in a patient of Moroccan origin. Haematologica. 92(11). e102–e105. 13 indexed citations
18.
Ortega, Margarita, et al.. (2006). Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics. 171(1). 57–64. 44 indexed citations
19.
Rodríguez, José A., Marı́a Dolores Caballero, Antonio Gutiérrez, et al.. (2005). Prolonged Survival in Patients with Angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO Experience.. Blood. 106(11). 2082–2082. 2 indexed citations
20.
Mollejo, Manuela, E. Lloret, Julia Solares, et al.. (1999). Splenic involvement by blastic mantle cell lymphoma (Large cell/anaplastic variant) mimicking splenic marginal zone lymphoma. American Journal of Hematology. 62(4). 242–246. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Martı́n Breakdown of academic impact, for papers by Guillermo Debén Breakdown of academic impact, for papers by Shuichi Miyawaki Breakdown of academic impact, for papers by Joan Bargay Breakdown of academic impact, for papers by Shin Fujisawa Breakdown of academic impact, for papers by FR Appelbaum Breakdown of academic impact, for papers by Enrico Gottardi Breakdown of academic impact, for papers by Gandhi Damaj Breakdown of academic impact, for papers by Akihiko Yokohama Breakdown of academic impact, for papers by W. Lange
Rankless by CCL
2026